Does anyone here understand how Nicolab licensing works? $884k recurring revenue divided by 149 hospitals sounds low to me at around $6k. The cost per acquisition would be much higher. Is it a low initial cost for a hospital to have access to the platform and then a cost each time they use strokeviewer, so you'd see revenue per hospital build as more doctors use it i.e. is there a charge for every scan?
- Forums
- IPOs
- Nico.lab Pre IPO
Does anyone here understand how Nicolab licensing works? $884k...
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)